Usa Financial Portformulas Corp Repligen Corp Transaction History

Usa Financial Portformulas Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$180.37 - $226.26 $485,736 - $609,318	-2,693 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$148.08 - $206.57 $186,728 - $260,484	-1,261 Reduced 31.89%	2,693 $516,000
Q3 2020 Oct 09, 2020	BUY	$122.51 - $158.27 $135,618 - $175,204	1,107 Added 38.88%	3,954 $583,000
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $268,557 - $399,946	2,847 New	2,847 $352,000
Q4 2019 Feb 07, 2020	SELL	$73.84 - $93.08 $188,882 - $238,098	-2,558 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $196,070 - $244,314	2,558 New	2,558 $196,000
Q1 2019 May 14, 2019	SELL	$49.45 - $62.8 $537,719 - $682,887	-10,874 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $524,779 - $749,001	10,874 New	10,874 $603,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.